ArticleACS omega2026
Halogenated Phenolic Ingredients of Household and Personal Care Products Modulate Thyroid Receptor Signaling.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endocrine-disrupting chemicals can interfere with thyroid hormone signaling and may contribute to adverse health outcomes. Among these, halogenated phenolic derivatives of household and personal care product (HPCP) ingredients are of increasing concern due to their structural resemblance to thyroid hormones. In this study, a comprehensive library of halogenated parabens, bisphenols, UV filters, and nonylphenols was evaluated for thyroid receptor (TR) modulatory activity using a GH3.TRE-Luc reporter assay. Halogenated bisphenol F derivatives displayed pronounced TR agonistic activity, with dichlorinated BPF emerging as the most potent agonist. In contrast, dihalogenated long-chain parabens, particularly dibrominated analogs, demonstrated antagonistic effects in the low micromolar range. Overall, our findings demonstrate that halogenation significantly influences TR modulation by phenolic HPCP ingredients, emphasizing the need for further investigation into their potential endocrine-disrupting impact.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.